Interferon alfa-2a in recurrent metastatic hemangiopericytoma

Med Pediatr Oncol. 2003 Mar;40(3):192-4. doi: 10.1002/mpo.10122.

Authors

Herwig Lackner¹, Christian Urban, Hans Jürgen Dornbusch, Wolfgang Schwinger, Reinhold Kerbl, Petra Sovinz

Affiliation

¹ Division of Pediatric Hematology/Oncology, Department of Pediatrics and Adolescence Medicine, Karl-Franzens-University, Graz, Austria.

PMID: 12518351
DOI: 10.1002/mpo.10122

No abstract available

Publication types

Case Reports

MeSH terms

Adolescent
Angiogenesis Inhibitors / therapeutic use*
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Bone Neoplasms / drug therapy*
Bone Neoplasms / secondary*
Bone Neoplasms / therapy
Brain Neoplasms / drug therapy*
Brain Neoplasms / pathology*
Brain Neoplasms / therapy
Combined Modality Therapy / methods
Dose Fractionation, Radiation
Hemangiopericytoma / drug therapy*
Hemangiopericytoma / secondary*
Hemangiopericytoma / therapy
Humans
Interferon alpha-2
Interferon-alpha / therapeutic use*
Magnetic Resonance Imaging
Male
Neoplasm Recurrence, Local / diagnosis
Neoplasm Recurrence, Local / therapy*
Neurosurgical Procedures
Recombinant Proteins
Stem Cell Transplantation / methods
Thalidomide / therapeutic use
Treatment Outcome

Substances

Angiogenesis Inhibitors
Interferon alpha-2
Interferon-alpha
Recombinant Proteins
Thalidomide